DE1530167U - - Google Patents

Info

Publication number
DE1530167U
DE1530167U DENDAT1530167D DE1530167DU DE1530167U DE 1530167 U DE1530167 U DE 1530167U DE NDAT1530167 D DENDAT1530167 D DE NDAT1530167D DE 1530167D U DE1530167D U DE 1530167DU DE 1530167 U DE1530167 U DE 1530167U
Authority
DE
Germany
Prior art keywords
miaoht
iht
inet
bit
wyuhwäo
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
DENDAT1530167D
Other languages
German (de)
English (en)
Publication of DE1530167U publication Critical patent/DE1530167U/de
Active legal-status Critical Current

Links

Landscapes

  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
DENDAT1530167D Active DE1530167U (OSRAM)

Publications (1)

Publication Number Publication Date
DE1530167U true DE1530167U (OSRAM)

Family

ID=830899

Family Applications (1)

Application Number Title Priority Date Filing Date
DENDAT1530167D Active DE1530167U (OSRAM)

Country Status (1)

Country Link
DE (1) DE1530167U (OSRAM)

Similar Documents

Publication Publication Date Title
Vogelzang et al. Subcutaneous interleukin-2 plus interferon alfa-2a in metastatic renal cancer: an outpatient multicenter trial.
DE1530167U (OSRAM)
Bouza et al. Infections in hairy-cell leukemia
Osteen et al. The national cancer data base report on breast cancer
Hunter et al. The prognostic significance of CA 125 half-life in patients with ovarian cancer who have received primary chemotherapy after surgical cytoreduction
Hunter et al. Angiosarcoma of the breast two case reports and a review of the literature
Namkoong et al. Comparative study of the patients with locally advanced stages I and II cervical cancer treated by radical surgery with and without preoperative adjuvant chemotherapy
Gottlieb Hazards of bacterial contamination of blood products
RU2107607C1 (ru) Металлорежущий инструмент для стружкообразующей обработки, уплотненная керамическая композиция, способ стружкообразующей обработки, способ уплотнения изделий, способ изготовления режущих пластин, керамическое изделие
ES2047280T3 (es) Herramienta compuesta que comporta una parte activa en diamante policristalino.
Karayalcin et al. Lymphocyte predominant Hodgkin Disease: Clinico‐pathologic features and results of treatment—The pediatric oncology group experience
Neijt Treatment of advanced ovarian cancer: 10 years of experience
Evans et al. Phase II study of amonafide: results of treatment and lessons learned from the study of an investigational agent in previously untreated patients with extensive small-cell lung cancer.
Stahel et al. Autologous bone marrow transplantation following high-dose chemotherapy with cyclophosphamide, BCNU and VP-16 in small cell carcinoma of the lung and a review of current literature
CN113682813B (zh) 冷链集装箱纸箱货物装卸夹具及方法
Brewton et al. A pilot study of diethyldithiocarbamate in patients with acquired immune deficiency syndrome (AIDS) and the AIDS-related complex
Blijham Prevention and treatment of organ toxicity during high-dose chemotherapy: an overview
Pizzocaro et al. Retroperitoneal lymphadenectomy and aggressive chemotherapy in nonbulky clinical stage II nonseminomatous germinal testis tumors
Norman et al. Infections of the bone, joint, and bursa
Ash et al. The relationship between blood ordered and blood administered in orthognathic surgery: A retrospective study
Land et al. First clinical experience with a new TCR/CD3-monoclonal antibody (BMA 031) in kidney transplant patients
Dimery et al. Phase II trial of carboplatin plus cisplatin in recurrent and advanced squamous cell carcinoma of the head and neck.
Bezwoda et al. Mitoxantrone, methotrexate, and 5‐fluorouracil combination chemotherapy as first‐line treatment in stage IV breast cancer
Buccheri et al. A phase II study of methotrexate, doxorubicin, cyclophosphamide, and lomustine chemotherapy and lonidamine in advanced non‐small cell lung cancer
White Prevention of infections in patients with neoplastic disease: use of a historical model for developmental strategies